WHO ICTRP trial
Randomised double-blind, placebo-controlled, crossover trial on the effects of…
ACTRN12606000027516 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12606000027516 |
|---|---|
| Public title | Randomised double-blind, placebo-controlled, crossover trial on the effects of modafinil on sleep apnea patients withdrawn from continuous positive airway pressure (cpap) treatment |
| Scientific title | Randomised double-blind, placebo-controlled, crossover trial on the effects of modafinil on sleep apnea patients withdrawn from continuous positive airway pressure (cpap) treatment |
| Primary sponsor | Woolcock Institute of Medical Research |
| Secondary sponsors | University of Sydney |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Obstructive sleep apnea; Obstructive sleep apnea;Respiratory - Sleep apnoea |
| Interventions | This randomised double-blind, placebo-controlled study will examine the efficacy of modafinil to counteract possible daytime sleepiness after CPAP withdrawal in long-term CPAP users. Subjects will be given an 'Autoset' CPAP machine to take… |
| Registration date | Jan 20, 2006 |
| Target size | 20 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: